Chief investigator of national PRISM trial thanks NDHT staff

The chief investigator of a national clinical trial looking into the prevention of miscarriages has thanked NDHT staff for supporting the trial.

Over a two-year period from 2015 to 2017, NDHT staff recruited 33 participants to the national PRISM Trial (PRogesterone In Spontaneous Miscarriage).

The PRISM trial aimed to evaluate the effectiveness of progesterone treatment in preventing miscarriage in women with early pregnancy bleeding, and the study was run through the early pregnancy assessment clinic. The research has shown that progesterone could increase live births in women with early pregnancy bleeding and a history of miscarriage.

The results of the trial have now been published in the New England Journal of Medicine.

The miscarriage, stillbirth and premature birth charity Tommy’s has produced a short video to summarise the results.

As a gesture of thanks for taking part in the trial, Professor Arri Coomarasamy, chief investigator of the PRISM trial, has sent a copy of his co-authored book Gynecologic and Obstetric Surgery – Challenges and Management Options to the principal investigator at NDHT, Mr Seumas Eckford. The book is dedicated to Mr Eckford and his team.

Chief investigator of national PRISM trial thanks NDHT staff

Members of the PRISM team (left to right): Michelle Vallely, staff nurse on Petter Ward, Louise Errol, Petter Ward manager, Mr Seumas Eckford, obs and gynae consultant, Helen Shelton, staff nurse on Petter Ward, Mr Mahmoud Moustapha, obs and gynae registrar, and Helen Black, clinical research nurse

Posted in News.

Last updated: June 10, 2019